---
figid: PMC9459544__tau-11-08-1177-f1
pmcid: PMC9459544
image_filename: tau-11-08-1177-f1.jpg
figure_link: /pmc/articles/PMC9459544/figure/f1/
number: Figure 1
figure_title: ''
caption: 'AS-IV protected renal function and alleviated renal tubular pathological
  damage caused by I/R. (A) Molecular structure of AS-IV. (B) Determination of CRE
  levels in AKI rat models. (C) Determination of urea levels in AKI rat models. (D)
  H&E staining of kidney tissue in AKI rat models. Magnification ×400. (E) PAS staining
  of kidney tissue from AKI rats. Magnification ×400. ##P<0.01, compared to the sham
  operation group; *P<0.05, **P<0.01, compared to the I/R group. CRE, creatinine;
  UREA, urea; AS-IV, Astragaloside IV; I/R, ischemia-reperfusion; AKI, acute kidney
  injury; PAS, periodic acid-Schiff.'
article_title: Astragaloside IV protects against ischemia/reperfusion (I/R)-induced
  kidney injury based on the Keap1-Nrf2/ARE signaling pathway.
citation: Yanyan Su, et al. Transl Androl Urol. 2022 Aug;11(8):1177-1188.
year: '2022'

doi: 10.21037/tau-22-505
journal_title: Translational Andrology and Urology
journal_nlm_ta: Transl Androl Urol
publisher_name: AME Publishing Company

keywords:
- Astragaloside IV
- acute kidney injury (AKI)
- chronic kidney injury
- keap1-Nrf2/ARE
- oxidative stress

---
